This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2008;48(2):68.

[Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation. Results of the BAFTA trial]

[Article in Russian]

PMID: 18261012

Review

[Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation. Results of the BAFTA trial]

[Article in Russian]

A A Liakishev. Kardiologiia. 2008.

. 2008;48(2):68.

Author

PMID: 18261012

No abstract available

PubMed Disclaimer

Similar articles

Stroke prevention in elderly patients with atrial fibrillation.
Garcia D, Hylek E. Garcia D, et al. Lancet. 2007 Aug 11;370(9586):460-1. doi: 10.1016/S0140-6736(07)61208-2. Lancet. 2007. PMID: 17693158 No abstract available.
Warfarin versus aspirin for stroke prevention (BAFTA).
Diug B, Lowthian J, Evans S. Diug B, et al. Lancet. 2007 Nov 10;370(9599):1606; author reply 1606-7. doi: 10.1016/S0140-6736(07)61678-X. Lancet. 2007. PMID: 17993355 No abstract available.
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, Murray E; BAFTA investigators; Midland Research Practices Network (MidReC). Mant J, et al. Lancet. 2007 Aug 11;370(9586):493-503. doi: 10.1016/S0140-6736(07)61233-1. Lancet. 2007. PMID: 17693178 Clinical Trial.
Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm.
Chaudhari D, Bhuriya R, Arora R. Chaudhari D, et al. Am J Ther. 2011 Jan;18(1):e1-e11. doi: 10.1097/MJT.0b013e3181d5ae5d. Am J Ther. 2011. PMID: 20460986 Review.
Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY. Potpara TS, et al. Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Adv Ther. 2012. PMID: 22684583 Review.

See all similar articles

Cited by

Could geriatric characteristics explain the under-prescription of anticoagulation therapy for older patients admitted with atrial fibrillation? A retrospective observational study.
De Breucker S, Herzog G, Pepersack T. De Breucker S, et al. Drugs Aging. 2010 Oct 1;27(10):807-13. doi: 10.2165/11537900-000000000-00000. Drugs Aging. 2010. PMID: 20883061
Prevalence of recommended anticoagulation by guidelines preadmission and its impact on the incidence of acute myocardial infarction (AMI) and in-hospital outcomes after AMI in atrial fibrillation patients.
Bai Y, Liu XY, Liu Y, Guo SD, Wang ZZ, Shi XB, Jin Y, Zhong P. Bai Y, et al. J Thromb Thrombolysis. 2022 Jul;54(1):91-96. doi: 10.1007/s11239-021-02622-0. Epub 2022 Jan 24. J Thromb Thrombolysis. 2022. PMID: 35067822

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information